24 related articles for article (PubMed ID: 9118468)
1. Chemotherapy in metastatic renal cell cancer.
Lilleby W; Fosså SD
World J Urol; 2005 Jul; 23(3):175-9. PubMed ID: 15726382
[TBL] [Abstract][Full Text] [Related]
2. Antiestrogens--tamoxifen, SERMs and beyond.
Dhingra K
Invest New Drugs; 1999; 17(3):285-311. PubMed ID: 10665480
[TBL] [Abstract][Full Text] [Related]
3. [Hormone therapy of advanced renal cancer with high-dose toremifene (Fareston)].
Gershanovich ML; Moiseenko VM; Vorob'ev AV; Kiapiulia K
Vopr Onkol; 1996; 42(5):105-9. PubMed ID: 9064893
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of toremifene for reversal of multidrug resistance in renal cell cancer patients treated with vinblastine.
Braybrooke JP; Vallis KA; Houlbrook S; Rockett H; Ellmén J; Anttila M; Ganesan TS; Harris AL; Talbot DC
Cancer Chemother Pharmacol; 2000; 46(1):27-34. PubMed ID: 10912574
[TBL] [Abstract][Full Text] [Related]
5. Open phase II study of high-dose toremifene as first-line therapy for advanced breast cancer.
Hietanen T; Hakala T; Baltina D; Johansson R; Numminen S; Helle L; Valavaara R; Thölix E
Oncology (Williston Park); 1997 May; 11(5 Suppl 4):37-40. PubMed ID: 9165505
[TBL] [Abstract][Full Text] [Related]
6. [A case of lung and pleural metastases from breast cancer responding to toremifene].
Inoue K; Tabei T; Kusawake T; Sugamata N; Suemasu K; Higashi Y; Kurosumi M
Gan To Kagaku Ryoho; 2001 Feb; 28(2):221-4. PubMed ID: 11242650
[TBL] [Abstract][Full Text] [Related]
7. High-dose toremifene vs tamoxifen in postmenopausal advanced breast cancer.
Gershanovich M; Hayes DF; Ellmén J; Vuorinen J
Oncology (Williston Park); 1997 May; 11(5 Suppl 4):29-36. PubMed ID: 9165504
[TBL] [Abstract][Full Text] [Related]
8. High-dose toremifene in advanced renal-cell carcinoma.
Gershanovich MM; Moiseyenko VM; Vorobjev AV; Käpylä H; Ellmén J; Anttila M
Cancer Chemother Pharmacol; 1997; 39(6):547-51. PubMed ID: 9118468
[TBL] [Abstract][Full Text] [Related]
9. Phase I and II studies of toremifene.
Hamm JT
Oncology (Williston Park); 1997 May; 11(5 Suppl 4):19-22. PubMed ID: 9165502
[TBL] [Abstract][Full Text] [Related]
10. Phase III trials of toremifene vs tamoxifen.
Gams R
Oncology (Williston Park); 1997 May; 11(5 Suppl 4):23-8. PubMed ID: 9165503
[TBL] [Abstract][Full Text] [Related]
11. Toremifene is an effective and safe alternative to tamoxifen in adjuvant endocrine therapy for breast cancer: results of four randomized trials.
Zhou WB; Ding Q; Chen L; Liu XA; Wang S
Breast Cancer Res Treat; 2011 Aug; 128(3):625-31. PubMed ID: 21553116
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacokinetics of toremifene.
Taras TL; Wurz GT; Linares GR; DeGregorio MW
Clin Pharmacokinet; 2000 Nov; 39(5):327-34. PubMed ID: 11108432
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]